FDA Grants Abraxane Priority Review for the Treatment of Pancreatic Cancer
May 24th 2013The FDA has granted priority review to paclitaxel protein-bound particles for injectable suspension, albumin-bound, or nab-paclitaxel, for metastatic pancreatic cancer when administered in combination with gemcitabine.